Evidence map›Paper›PMID 34545250›Full record

ReviewNature immunology2021

Repositioning T

Selma Tuzlak, Anne S Dejean, Matteo Iannacone, Francisco J Quintana, Ari Waisman, Florent Ginhoux, Thomas Korn, Burkhard Becher

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Atopic dermatitis.Nature reviews. Disease primers · 2026
    Review
  5. Review
  6. Guidelines for T cell nomenclature.Nature reviews. Immunology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Selma Tuzlak *Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Anne S DejeanInstitut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITy), INSERM UMR1291-CNRS UMR5051-Université Toulouse III, Toulouse, France.ORCID http://orcid.org/0000-0002-8846-1113
Matteo IannaconeDivision of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0002-9370-2671
Francisco J QuintanaAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ari WaismanInstitute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4304-8234
Florent Ginhoux *Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.ORCID http://orcid.org/0000-0002-2857-7755
Thomas Korn *Institute for Experimental Neuroimmunology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. thomas.korn@tum.de.ORCID http://orcid.org/0000-0002-3633-0955
Burkhard Becher *Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. becher@immunology.uzh.ch.ORCID http://orcid.org/0000-0002-1541-7867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When helper T (T

Indexed as

AnimalsB-LymphocytesCell PlasticityCytokinesEosinophilsEpitheliumHumansImmunity, InnateLymphocytesPhagocytesT-Lymphocytes, Helper-InducerCytokines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.